Do analysts recommend IOSP or CBT?

Cabot has a consensus target price of $85.80, indicating a potential downside of 2.62%. Given Cabot's stronger consensus rating and higher possible upside, analysts plainly believe Cabot is more favorable than Innospec. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innospec 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cabot 1 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14

Which has stronger valuation & earnings, IOSP or CBT?

Cabot has higher revenue and earnings than Innospec. Cabot is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Innospec $1.78B 1.19 $116.60M $4.59 18.73 Cabot $3.71B 1.22 $331M $5.29 16.66

Is IOSP or CBT more profitable?

Cabot has a net margin of 7.97% compared to Innospec's net margin of 6.38%. Cabot's return on equity of 21.33% beat Innospec's return on equity. Company Net Margins Return on Equity Return on Assets Innospec 6.38% 9.32% 6.79% Cabot 7.97% 21.33% 9.48%

Does the media favor IOSP or CBT?

In the previous week, Cabot had 6 more articles in the media than Innospec. MarketBeat recorded 10 mentions for Cabot and 4 mentions for Innospec. Cabot's average media sentiment score of 0.84 beat Innospec's score of 0.80 indicating that Cabot is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Innospec 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cabot 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, ASIX or CBT?

Cabot has higher revenue and earnings than AdvanSix. Cabot is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AdvanSix $1.55B 0.35 $49.29M $0.37 54.32 Cabot $3.71B 1.22 $331M $5.29 16.66

Is ASIX or CBT more profitable?

Cabot has a net margin of 7.97% compared to AdvanSix's net margin of 0.67%. Cabot's return on equity of 21.33% beat AdvanSix's return on equity. Company Net Margins Return on Equity Return on Assets AdvanSix 0.67% 2.18% 1.05% Cabot 7.97% 21.33% 9.48%

Does the media favor ASIX or CBT?

In the previous week, Cabot had 4 more articles in the media than AdvanSix. MarketBeat recorded 10 mentions for Cabot and 6 mentions for AdvanSix. Cabot's average media sentiment score of 0.84 beat AdvanSix's score of 0.47 indicating that Cabot is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdvanSix 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cabot 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, CBT or AVNT?

Cabot has higher revenue and earnings than Avient. Cabot is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cabot $3.71B 1.22 $331M $5.29 16.66 Avient $3.26B 1.02 $81.90M $1.72 21.12

Is CBT or AVNT more profitable?

Cabot has a net margin of 7.97% compared to Avient's net margin of 4.81%. Cabot's return on equity of 21.33% beat Avient's return on equity. Company Net Margins Return on Equity Return on Assets Cabot 7.97% 21.33% 9.48% Avient 4.81% 11.11% 4.40%

Does the media refer more to CBT or AVNT?

In the previous week, Cabot had 6 more articles in the media than Avient. MarketBeat recorded 10 mentions for Cabot and 4 mentions for Avient. Avient's average media sentiment score of 1.07 beat Cabot's score of 0.84 indicating that Avient is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabot 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avient 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is CBT or CC more profitable?

Cabot has a net margin of 7.97% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Cabot's return on equity. Company Net Margins Return on Equity Return on Assets Cabot 7.97% 21.33% 9.48% Chemours -6.82% 52.49% 1.78%

Does the media favor CBT or CC?

In the previous week, Cabot had 1 more articles in the media than Chemours. MarketBeat recorded 10 mentions for Cabot and 9 mentions for Chemours. Cabot's average media sentiment score of 0.84 beat Chemours' score of 0.83 indicating that Cabot is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabot 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemours 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CBT or EMN?

In the previous week, Eastman Chemical had 12 more articles in the media than Cabot. MarketBeat recorded 22 mentions for Eastman Chemical and 10 mentions for Cabot. Eastman Chemical's average media sentiment score of 0.99 beat Cabot's score of 0.84 indicating that Eastman Chemical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabot 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Eastman Chemical 10 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cabot (CBT) Competitors

$88.10 -0.13 (-0.14%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$88.06 -0.05 (-0.05%)

As of 07/31/2026 07:34 PM Eastern

Compare

CBT vs. IOSP, ASIX, AVNT, CC, and EMN

Should you buy Cabot stock or one of its competitors? MarketBeat compares Cabot with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cabot include Innospec (IOSP), AdvanSix (ASIX), Avient (AVNT), Chemours (CC), and Eastman Chemical (EMN).

How does Cabot compare to Innospec?

Innospec (NASDAQ:IOSP) and Cabot (NYSE:CBT) are both mid-cap materials companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

96.6% of Innospec shares are held by institutional investors. Comparatively, 93.2% of Cabot shares are held by institutional investors. 1.5% of Innospec shares are held by insiders. Comparatively, 3.1% of Cabot shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cabot has a net margin of 7.97% compared to Innospec's net margin of 6.38%. Cabot's return on equity of 21.33% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innospec	6.38%	9.32%	6.79%
Cabot	7.97%	21.33%	9.48%

In the previous week, Cabot had 6 more articles in the media than Innospec. MarketBeat recorded 10 mentions for Cabot and 4 mentions for Innospec. Cabot's average media sentiment score of 0.84 beat Innospec's score of 0.80 indicating that Cabot is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Innospec	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cabot	4 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 2.1%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.1%. Innospec pays out 40.1% of its earnings in the form of a dividend. Cabot pays out 35.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Innospec has increased its dividend for 11 consecutive years and Cabot has increased its dividend for 14 consecutive years. Cabot is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Innospec has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market. Comparatively, Cabot has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

Cabot has a consensus target price of $85.80, indicating a potential downside of 2.62%. Given Cabot's stronger consensus rating and higher possible upside, analysts plainly believe Cabot is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

Cabot has higher revenue and earnings than Innospec. Cabot is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innospec	$1.78B	1.19	$116.60M	$4.59	18.73
Cabot	$3.71B	1.22	$331M	$5.29	16.66

Summary

Cabot beats Innospec on 16 of the 19 factors compared between the two stocks.

How does Cabot compare to AdvanSix?

AdvanSix (NYSE:ASIX) and Cabot (NYSE:CBT) are both materials companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

In the previous week, Cabot had 4 more articles in the media than AdvanSix. MarketBeat recorded 10 mentions for Cabot and 6 mentions for AdvanSix. Cabot's average media sentiment score of 0.84 beat AdvanSix's score of 0.47 indicating that Cabot is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdvanSix	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cabot	4 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot has a net margin of 7.97% compared to AdvanSix's net margin of 0.67%. Cabot's return on equity of 21.33% beat AdvanSix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdvanSix	0.67%	2.18%	1.05%
Cabot	7.97%	21.33%	9.48%

AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.2%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.1%. AdvanSix pays out 173.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cabot pays out 35.7% of its earnings in the form of a dividend. AdvanSix has raised its dividend for 2 consecutive years and Cabot has raised its dividend for 14 consecutive years.

AdvanSix presently has a consensus price target of $22.50, indicating a potential upside of 11.94%. Cabot has a consensus price target of $85.80, indicating a potential downside of 2.62%. Given AdvanSix's higher possible upside, research analysts clearly believe AdvanSix is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdvanSix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

86.4% of AdvanSix shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 5.0% of AdvanSix shares are owned by insiders. Comparatively, 3.1% of Cabot shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

AdvanSix has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, Cabot has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

Cabot has higher revenue and earnings than AdvanSix. Cabot is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdvanSix	$1.55B	0.35	$49.29M	$0.37	54.32
Cabot	$3.71B	1.22	$331M	$5.29	16.66

Summary

Cabot beats AdvanSix on 14 of the 19 factors compared between the two stocks.

How does Cabot compare to Avient?

Cabot (NYSE:CBT) and Avient (NYSE:AVNT) are both mid-cap materials companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.1%. Avient pays an annual dividend of $1.10 per share and has a dividend yield of 3.0%. Cabot pays out 35.7% of its earnings in the form of a dividend. Avient pays out 64.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years and Avient has raised its dividend for 1 consecutive years.

Cabot has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market. Comparatively, Avient has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market.

Cabot presently has a consensus target price of $85.80, indicating a potential downside of 2.62%. Avient has a consensus target price of $45.71, indicating a potential upside of 25.82%. Given Avient's stronger consensus rating and higher probable upside, analysts clearly believe Avient is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
Avient	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

93.2% of Cabot shares are owned by institutional investors. Comparatively, 95.5% of Avient shares are owned by institutional investors. 3.1% of Cabot shares are owned by insiders. Comparatively, 0.9% of Avient shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Cabot had 6 more articles in the media than Avient. MarketBeat recorded 10 mentions for Cabot and 4 mentions for Avient. Avient's average media sentiment score of 1.07 beat Cabot's score of 0.84 indicating that Avient is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	4 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avient	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot has a net margin of 7.97% compared to Avient's net margin of 4.81%. Cabot's return on equity of 21.33% beat Avient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	7.97%	21.33%	9.48%
Avient	4.81%	11.11%	4.40%

Cabot has higher revenue and earnings than Avient. Cabot is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.22	$331M	$5.29	16.66
Avient	$3.26B	1.02	$81.90M	$1.72	21.12

Summary

Cabot beats Avient on 11 of the 19 factors compared between the two stocks.

How does Cabot compare to Chemours?

Cabot (NYSE:CBT) and Chemours (NYSE:CC) are both mid-cap materials companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

Cabot has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.22	$331M	$5.29	16.66
Chemours	$5.81B	0.43	-$386M	-$2.64	N/A

Cabot has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, Chemours has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market.

Cabot currently has a consensus price target of $85.80, indicating a potential downside of 2.62%. Chemours has a consensus price target of $24.10, indicating a potential upside of 44.88%. Given Chemours' stronger consensus rating and higher possible upside, analysts clearly believe Chemours is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
Chemours	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58

93.2% of Cabot shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 3.1% of Cabot shares are owned by company insiders. Comparatively, 0.9% of Chemours shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Cabot had 1 more articles in the media than Chemours. MarketBeat recorded 10 mentions for Cabot and 9 mentions for Chemours. Cabot's average media sentiment score of 0.84 beat Chemours' score of 0.83 indicating that Cabot is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	4 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemours	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot has a net margin of 7.97% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Cabot's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	7.97%	21.33%	9.48%
Chemours	-6.82%	52.49%	1.78%

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.1%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.1%. Cabot pays out 35.7% of its earnings in the form of a dividend. Chemours pays out -13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has increased its dividend for 14 consecutive years. Cabot is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Cabot beats Chemours on 12 of the 20 factors compared between the two stocks.

How does Cabot compare to Eastman Chemical?

Cabot (NYSE:CBT) and Eastman Chemical (NYSE:EMN) are both mid-cap materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Cabot has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market. Comparatively, Eastman Chemical has a beta of 1.06, meaning that its share price is 6% more volatile than the broader market.

Eastman Chemical has higher revenue and earnings than Cabot. Cabot is trading at a lower price-to-earnings ratio than Eastman Chemical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.22	$331M	$5.29	16.66
Eastman Chemical	$8.75B	0.92	$474M	$3.84	18.24

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.1%. Eastman Chemical pays an annual dividend of $3.36 per share and has a dividend yield of 4.8%. Cabot pays out 35.7% of its earnings in the form of a dividend. Eastman Chemical pays out 87.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cabot has raised its dividend for 14 consecutive years and Eastman Chemical has raised its dividend for 15 consecutive years. Eastman Chemical is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

93.2% of Cabot shares are held by institutional investors. Comparatively, 83.7% of Eastman Chemical shares are held by institutional investors. 3.1% of Cabot shares are held by company insiders. Comparatively, 2.6% of Eastman Chemical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Eastman Chemical had 12 more articles in the media than Cabot. MarketBeat recorded 22 mentions for Eastman Chemical and 10 mentions for Cabot. Eastman Chemical's average media sentiment score of 0.99 beat Cabot's score of 0.84 indicating that Eastman Chemical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	4 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Eastman Chemical	10 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot has a net margin of 7.97% compared to Eastman Chemical's net margin of 4.99%. Cabot's return on equity of 21.33% beat Eastman Chemical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	7.97%	21.33%	9.48%
Eastman Chemical	4.99%	9.53%	3.80%

Cabot currently has a consensus price target of $85.80, suggesting a potential downside of 2.62%. Eastman Chemical has a consensus price target of $80.50, suggesting a potential upside of 14.93%. Given Eastman Chemical's stronger consensus rating and higher possible upside, analysts plainly believe Eastman Chemical is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
Eastman Chemical	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Eastman Chemical beats Cabot on 11 of the 19 factors compared between the two stocks.

Get Cabot News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CBT vs. The Competition

Export

Metric	Cabot	Chemicals Industry	Materials Sector	NYSE Exchange
Market Cap	$4.54B	$11.17B	$4.60B	$23.69B
Dividend Yield	2.15%	2.85%	4.76%	4.22%
P/E Ratio	16.66	21.15	20.11	30.98
Price / Sales	1.22	50.70	4,733.62	19.22
Price / Cash	8.47	14.97	24.35	18.73
Price / Book	2.75	3.56	8.19	4.76
Net Income	$331M	$223.51M	$155.10M	$1.07B
7 Day Performance	-2.27%	0.14%	-0.58%	0.35%
1 Month Performance	2.10%	0.13%	-3.10%	-0.55%
1 Year Performance	22.39%	20.90%	37.88%	19.21%

Cabot Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CBT Cabot	3.9339 of 5 stars	$88.11 -0.1%	$85.80 -2.6%	+22.4%	$4.54B	$3.71B	16.66	4,100	News Coverage Upcoming Earnings Analyst Downgrade
IOSP Innospec	3.6497 of 5 stars	$85.63 +1.0%	N/A	+9.5%	$2.09B	$1.78B	18.66	2,450	Upcoming Earnings
ASIX AdvanSix	3.4086 of 5 stars	$20.25 -3.8%	$22.50 +11.1%	+4.6%	$567.49M	$1.55B	54.73	1,410	News Coverage Upcoming Earnings
AVNT Avient	4.1108 of 5 stars	$36.47 -3.0%	$45.71 +25.4%	+7.6%	$3.45B	$3.26B	21.20	9,000	News Coverage Positive News Upcoming Earnings
CC Chemours	4.5151 of 5 stars	$16.97 -1.4%	$24.10 +42.0%	+44.7%	$2.59B	$5.81B	N/A	5,700	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CBT) was last updated on 8/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cabot (CBT) Competitors